Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA Through New Agreement with Lemonaid Health

PTPI Stock  USD 0.35  0.01  2.78%   
Under 61% of Petros Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Petros Pharmaceuticals suggests that many traders are alarmed. Petros Pharmaceuticals' investing sentiment shows overall attitude of investors towards Petros Pharmaceuticals.
  
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Healths ED patients NEW YORK, NY ACCESSWIRE April 23, 2024 Petros Pharmaceuticals, Inc. ...

Read at finance.yahoo.com
Yahoo News
  

Petros Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Petros Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Petros Pharmaceuticals Fundamental Analysis

We analyze Petros Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Petros Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Petros Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Sales

Price To Sales Comparative Analysis

Petros Pharmaceuticals is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Petros Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Petros Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Petros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Petros Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Petros Pharmaceuticals Related Equities

LFCRLifecore Biomedical   6.59   
0%
60.0%
EVOKEvoke Pharma   0.49   
0%
4.0%
CPIXCumberland Pharmaceuticals   0.82   
7.0%
0%
SNOASonoma Pharmaceuticals   1.05   
9.0%
0%
SHPHShuttle Pharmaceuticals   1.33   
12.0%
0%
AKANAkanda Corp   1.90   
17.0%
0%
SXTCChina SXT   2.33   
21.0%
0%
TKNOAlpha Teknova   2.88   
26.0%
0%
SBFMSunshine Biopharma   3.02   
27.0%
0%
CPHIChina Pharma   4.76   
43.0%
0%
PRFXPainreform   10.98   
100.0%
0%

Complementary Tools for Petros Stock analysis

When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk